Jacobs Levy Equity Management Inc. increased its position in American Vanguard Co. (NYSE:AVD - Free Report) by 63.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 444,574 shares of the basic materials company's stock after acquiring an additional 173,349 shares during the period. Jacobs Levy Equity Management Inc. owned approximately 1.54% of American Vanguard worth $2,058,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. PNC Financial Services Group Inc. increased its stake in shares of American Vanguard by 133.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,575 shares of the basic materials company's stock worth $30,000 after acquiring an additional 3,753 shares during the period. Intech Investment Management LLC acquired a new stake in American Vanguard during the 4th quarter worth about $50,000. Bayesian Capital Management LP purchased a new position in shares of American Vanguard during the 4th quarter valued at about $54,000. Ieq Capital LLC acquired a new position in shares of American Vanguard in the 4th quarter valued at about $54,000. Finally, Susquehanna Fundamental Investments LLC acquired a new position in shares of American Vanguard in the 4th quarter valued at about $68,000. Institutional investors and hedge funds own 79.04% of the company's stock.
American Vanguard Stock Performance
Shares of NYSE AVD traded up $0.03 during midday trading on Wednesday, reaching $4.40. 19,834 shares of the stock were exchanged, compared to its average volume of 269,000. The company has a quick ratio of 0.79, a current ratio of 1.89 and a debt-to-equity ratio of 0.55. The firm has a market cap of $126.67 million, a price-to-earnings ratio of -4.27 and a beta of 1.24. The firm has a 50-day simple moving average of $4.18 and a two-hundred day simple moving average of $4.93. American Vanguard Co. has a twelve month low of $3.28 and a twelve month high of $9.84.
Wall Street Analysts Forecast Growth
Separately, Lake Street Capital set a $14.00 target price on American Vanguard in a report on Tuesday, January 21st.
View Our Latest Research Report on AVD
About American Vanguard
(
Free Report)
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Recommended Stories

Before you consider American Vanguard, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Vanguard wasn't on the list.
While American Vanguard currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.